News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan Inc. (MYL) Will Not Shy Away From Pursuing "Frivolous" Patents


9/12/2013 8:23:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Multinational drug-maker Mylan has hinted that it is willing to get its hands dirty in India, even if this meant pursuing “frivolous or invalid patents” to bring in less-expensive generic medicines. “There is a clear distinction between large brand pharmaceutical multinationals and Mylan,” said President Rajiv Malik. Mylan is a multinational, but it is also a generic and specialty company focused on improving access to quality, affordable medicines, he clarifies.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES